IP Library › Granted Patent US 10,543,278
Granted Patent B2
US 10,543,278 · App. 14/427,711 · Granted Jan 28, 2020

Immunoparticles and methods of generating and using same

Inventors: Ranit Kedmi (Tel-Aviv, IL); Dan Peer (Kiryat-Ono, IL)
Assignee: Ramot at Tel-Aviv University Ltd.
A61K47/48561C07K16/2809C07K16/2839C07K16/2896C07K16/30C07K16/4283A61K2039/505C07K2317/622C07K2317/77C07K2317/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,543,278
App. No.
14/427,711
Granted
Jan 28, 2020
Kind
B2
Abstract

A pharmaceutical composition comprising an immunoparticle is provided. The pharmaceutical composition comprising a monoclonal secondary antibody immunocomplexed with a primary antibody, wherein said monoclonal secondary antibody is coupled on an outer surface of a particle and wherein said particle is loaded with a pharmaceutical agent.

Claims (7)

1. An immunoparticle comprising a humanized secondary antibody coupled on an outer surface of a particle, wherein said secondary antibody is bound specifically to an Fc region of an isolated humanized or human primary antibody.

2. The immunoparticle of claim 1 , wherein said immunoparticle is loaded with a pharmaceutical agent.

3. A pharmaceutical composition comprising the immunoparticle of claim 1 .

4. A universal kit for in-vivo delivery of a pharmaceutical agent, the kit comprising the immunoparticle of claim 2 .

5. The immunoparticle of claim 1 , wherein said isolated humanized secondary antibody is an IgG1.

6. The immunoparticle of claim 1 , wherein said isolated humanized secondary antibody binds an IgG humanized or human primary antibody.

7. The immunoparticle of claim 1 , wherein said isolated humanized or human primary antibody is IgG.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2015
From: KEDMI, RANIT; PEER, DAN
To: RAMOT AT TEL-AVIV UNIVERSITY LTD.
Reel/Frame 035364/0390 →
Priority Claims (1)
IL 221909 · Sep 12, 2012 · national
Continuity (1)
Related Publication 20150246135A1 · Sep 3, 2015
Cited By (1)
US 12,668,643